CoLucid Pharmaceuticals, Inc. — Form D
CoLucid Pharmaceuticals, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-26. The offering totals $37.1M, of which $37.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-01-26
- Form: D
- Accession: 0001625010-15-000005
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $37.1M
- Amount sold: $37.1M
- Investors: 11
- Date of first sale: 2015-01-12
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-232838
Issuer
- Name: CoLucid Pharmaceuticals, Inc.
- CIK: 0001348649
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: 2520 MERIDIAN PARKWAY, DURHAM, NC, 27713
- Phone: 919-806-4304
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Martin C Edwards | Director | Hellerup, G7 |
| Luc C Marengere | Director | Westmount, A8 |
| Richard J Markham | Director | Princeton, NJ |
| Mathers P Thomas | Director | Durham, NC |
| Bernice C Kuca | Executive Officer | Durham, NC |
| Mathers P Thomas | Executive Officer | Durham, NC |
| Thomas P Mathers | Director | Durham, NC |
| Thomas P Mathers | Executive Officer | Durham, NC |
| Nadia M Rupniak | Executive Officer | Durham, NC |
| Timothy C Gupton | Executive Officer | Raleigh, NC |
| Arthur M Pappas | Director | Durham, NC |
| Arthur M Pappas | Executive Officer | Durham, NC |
| James F White | Director | Durham, NC |
| James F White | Executive Officer | Durham, NC |
| Daniel L Boeglin | Executive Officer | Indianapolis, IN |
| Nadia C Rupniak | Executive Officer | Durham, NC |
| Jesse I Treu | Director | Princeton, NJ |
| Richard I Markham | Director | Princeton, NJ |
Other filings by this issuer (4)
More